AMGEN INC (AMGN) Fundamental Analysis & Valuation
NASDAQ:AMGN • US0311621009
Current stock price
340 USD
-2.57 (-0.75%)
At close:
344 USD
+4 (+1.18%)
Pre-Market:
This AMGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AMGN Profitability Analysis
1.1 Basic Checks
- AMGN had positive earnings in the past year.
- In the past year AMGN had a positive cash flow from operations.
- AMGN had positive earnings in each of the past 5 years.
- Each year in the past 5 years AMGN had a positive operating cash flow.
1.2 Ratios
- AMGN has a Return On Assets of 8.51%. This is amongst the best in the industry. AMGN outperforms 92.84% of its industry peers.
- The Return On Equity of AMGN (89.06%) is better than 99.23% of its industry peers.
- The Return On Invested Capital of AMGN (16.85%) is better than 96.71% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for AMGN is significantly below the industry average of 27.63%.
- The 3 year average ROIC (14.35%) for AMGN is below the current ROIC(16.85%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROIC | 16.85% |
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
1.3 Margins
- With an excellent Profit Margin value of 20.98%, AMGN belongs to the best of the industry, outperforming 93.04% of the companies in the same industry.
- AMGN's Profit Margin has declined in the last couple of years.
- AMGN's Operating Margin of 34.19% is amongst the best of the industry. AMGN outperforms 96.33% of its industry peers.
- In the last couple of years the Operating Margin of AMGN has grown nicely.
- AMGN has a better Gross Margin (73.30%) than 81.62% of its industry peers.
- AMGN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% |
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
2. AMGN Health Analysis
2.1 Basic Checks
- AMGN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, AMGN has more shares outstanding
- The number of shares outstanding for AMGN has been reduced compared to 5 years ago.
- The debt/assets ratio for AMGN has been reduced compared to a year ago.
2.2 Solvency
- AMGN has a debt to FCF ratio of 6.74. This is a slightly negative value and a sign of low solvency as AMGN would need 6.74 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 6.74, AMGN belongs to the best of the industry, outperforming 90.72% of the companies in the same industry.
- AMGN has a Debt/Equity ratio of 5.78. This is a high value indicating a heavy dependency on external financing.
- AMGN's Debt to Equity ratio of 5.78 is on the low side compared to the rest of the industry. AMGN is outperformed by 82.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC9.07%
2.3 Liquidity
- AMGN has a Current Ratio of 1.14. This is a normal value and indicates that AMGN is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of AMGN (1.14) is worse than 84.72% of its industry peers.
- AMGN has a Quick Ratio of 1.14. This is a bad value and indicates that AMGN is not financially healthy enough and could expect problems in meeting its short term obligations.
- AMGN has a Quick ratio of 0.90. This is amonst the worse of the industry: AMGN underperforms 86.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 |
3. AMGN Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 10.24% over the past year.
- The Earnings Per Share has been growing slightly by 5.65% on average over the past years.
- AMGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.95%.
- AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.65% yearly.
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
3.2 Future
- Based on estimates for the next years, AMGN will show a small growth in Earnings Per Share. The EPS will grow by 4.89% on average per year.
- Based on estimates for the next years, AMGN will show a small growth in Revenue. The Revenue will grow by 3.17% on average per year.
EPS Next Y4.46%
EPS Next 2Y4.2%
EPS Next 3Y4.06%
EPS Next 5Y4.89%
Revenue Next Year4.1%
Revenue Next 2Y3.29%
Revenue Next 3Y3.03%
Revenue Next 5Y3.17%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. AMGN Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 15.56, which indicates a correct valuation of AMGN.
- 94.97% of the companies in the same industry are more expensive than AMGN, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 26.21, AMGN is valued a bit cheaper.
- The Price/Forward Earnings ratio is 14.90, which indicates a correct valuation of AMGN.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of AMGN indicates a rather cheap valuation: AMGN is cheaper than 95.74% of the companies listed in the same industry.
- AMGN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.56 | ||
| Fwd PE | 14.9 |
4.2 Price Multiples
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMGN indicates a rather cheap valuation: AMGN is cheaper than 94.78% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.63 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of AMGN may justify a higher PE ratio.
PEG (NY)3.49
PEG (5Y)2.75
EPS Next 2Y4.2%
EPS Next 3Y4.06%
5. AMGN Dividend Analysis
5.1 Amount
- AMGN has a Yearly Dividend Yield of 2.89%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.11, AMGN pays a better dividend. On top of this AMGN pays more dividend than 98.84% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, AMGN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.89% |
5.2 History
- On average, the dividend of AMGN grows each year by 9.41%, which is quite nice.
- AMGN has been paying a dividend for at least 10 years, so it has a reliable track record.
- AMGN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.41%
Div Incr Years14
Div Non Decr Years14
5.3 Sustainability
- AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y4.2%
EPS Next 3Y4.06%
AMGN Fundamentals: All Metrics, Ratios and Statistics
340
-2.57 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-03 2026-02-03/amc
Earnings (Next)04-29 2026-04-29/amc
Inst Owners85.05%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner Change3.94%
Market Cap183.28B
Revenue(TTM)36.75B
Net Income(TTM)7.71B
Analysts70.7
Price Target360.65 (6.07%)
Short Float %2.66%
Short Ratio4.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.89% |
Yearly Dividend9.01
Dividend Growth(5Y)9.41%
DP0%
Div Incr Years14
Div Non Decr Years14
Ex-Date05-15 2026-05-15 (2.52)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.92%
Min EPS beat(2)9.56%
Max EPS beat(2)10.28%
EPS beat(4)4
Avg EPS beat(4)10.8%
Min EPS beat(4)9.56%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)6.29%
EPS beat(12)11
Avg EPS beat(12)5.41%
EPS beat(16)14
Avg EPS beat(16)4.51%
Revenue beat(2)2
Avg Revenue beat(2)3.3%
Min Revenue beat(2)2.11%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.61%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.11%
PT rev (3m)7.76%
EPS NQ rev (1m)-1.38%
EPS NQ rev (3m)-6.12%
EPS NY rev (1m)0%
EPS NY rev (3m)1.9%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)2.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.56 | ||
| Fwd PE | 14.9 | ||
| P/S | 4.99 | ||
| P/FCF | 22.63 | ||
| P/OCF | 18.41 | ||
| P/B | 21.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)21.85
EY6.43%
EPS(NY)22.82
Fwd EY6.71%
FCF(TTM)15.03
FCFY4.42%
OCF(TTM)18.47
OCFY5.43%
SpS68.17
BVpS16.06
TBVpS-59.91
PEG (NY)3.49
PEG (5Y)2.75
Graham Number88.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROCE | 19.3% | ||
| ROIC | 16.85% | ||
| ROICexc | 19.6% | ||
| ROICexgc | 73.08% | ||
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% | ||
| FCFM | 22.04% |
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
ROICexc(3y)16.88%
ROICexc(5y)18.44%
ROICexgc(3y)72.7%
ROICexgc(5y)79.08%
ROCE(3y)16.43%
ROCE(5y)17.69%
ROICexgc growth 3Y-3.21%
ROICexgc growth 5Y2.03%
ROICexc growth 3Y4.63%
ROICexc growth 5Y5.17%
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
F-Score7
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 5.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 105.05% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | N/A |
F-Score7
WACC9.07%
ROIC/WACC1.86
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)4.09%
Cap/Sales(5y)3.84%
Profit Quality(3y)156.25%
Profit Quality(5y)149.01%
High Growth Momentum
Growth
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
EPS Next Y4.46%
EPS Next 2Y4.2%
EPS Next 3Y4.06%
EPS Next 5Y4.89%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
Revenue Next Year4.1%
Revenue Next 2Y3.29%
Revenue Next 3Y3.03%
Revenue Next 5Y3.17%
EBIT growth 1Y73.11%
EBIT growth 3Y16.9%
EBIT growth 5Y12.12%
EBIT Next Year31.85%
EBIT Next 3Y9.8%
EBIT Next 5Y8.55%
FCF growth 1Y-22.07%
FCF growth 3Y-2.67%
FCF growth 5Y-3.91%
OCF growth 1Y-13.33%
OCF growth 3Y0.81%
OCF growth 5Y-1.05%
AMGEN INC / AMGN Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to AMGN.
What is the valuation status of AMGEN INC (AMGN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (AMGN). This can be considered as Fairly Valued.
How profitable is AMGEN INC (AMGN) stock?
AMGEN INC (AMGN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of AMGEN INC (AMGN) stock?
The Price/Earnings (PE) ratio for AMGEN INC (AMGN) is 15.56 and the Price/Book (PB) ratio is 21.17.
How financially healthy is AMGEN INC?
The financial health rating of AMGEN INC (AMGN) is 3 / 10.